Table of contents

Original Articles: Ovarian Cancer

• Bowel Obstruction and Survival in Patients With Advanced Ovarian Cancer: Analysis of Prognostic Variables (1 January, 2009)

  Enrico Sartori, Francesca Chiudinelli, Brunella Pasinetti, Tiziano Maggino
• The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas (1 January, 2009)

  Shannon Salvador, Blake Gilks, Martin Köbel, David Huntsman, Barry Rosen, Dianne Miller
• Ovarian Epithelial Dysplasia and Prophylactic Oophorectomy for Genetic Risk (1 January, 2009)

  Gautier Chêne, Frederique Penault-Llorca, Guillaume Le Bouëdec, Florence Mishellany, Marie-Melanie Dauplat, Patricia Jaffeux, Bruno Aublet-Cuvelier, Jean Luc Pouly, Pierre Déchelotte, Jacques Dauplat
• Physical Activity in Ovarian Cancer Survivors: Associations With Fatigue, Sleep, and Psychosocial Functioning (1 January, 2009)

  Clare Stevinson, Helen Steed, Wylam Faught, Katia Tonkin, Jeffrey K. Vallance, Aliya B. Ladha, Alexandra Schepansky, Valerie Capstick, Kerry S. Courneya
• Stratification of Venous Thromboembolism Risk in Ovarian Cancer Patients During Chemotherapy (1 January, 2009)

  Liliana Mereu, Saverio Tateo, Catherine Klersy, Eva Martinotti Gabellotti, Franco Polatti
• Clinicopathologic Characteristics of Malignant Germ Cell Tumors in the Ovaries of Korean Women: A Korean Gynecologic Oncology Group Study (1 January, 2009)

  Ki Heon Lee, In Ho Lee, Byoung Gie Kim, Joo Hyun Nam, Won Kyu Kim, Soon Beom Kang, Sang Young Ryu, Chi Heum Cho, Ho Sun Choi, Kyung Tai Kim
• Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian Cancer: Same Prognosis in a Large Randomized Trial (1 January, 2009)

  P. J. Timmers, A. H. Zwinderman, I. Teodorovic, I. Vergote, J. B. Trimbos
• Influence of Department Volume on Survival for Ovarian Cancer: Results From a Prospective Quality Assurance Program of the Austrian Association for Gynecologic Oncology (1 January, 2009)

  Christian Marth, Sonja Hiebl, Willi Oberaigner, Raimund Winter, Sepp Leodolter, Paul Sevelda
• Recent Developments on the Significance and Pathogenesis of Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) (1 January, 2009)

  Oluwole Fadare
• Prognostic Value of Human Epidermal Growth Factor Receptor 2 (Her-2)/neu in Patients With Advanced Ovarian Cancer Treated With Platinum/Paclitaxel as First-Line Chemotherapy: A Retrospective Evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany (1 January, 2009)

  Jacobus Pfisterer, Andreas Du Bois, Eva-Katrin Bentz, Friedrich Kommoss, Philipp Harter, Jens Huober, Barbara Schmalfeldt, Nicole Burchardi, Norbert Arnold, Felix Hilpert
• A Population-Based 5-Year Cohort Study Including All Cases of Epithelial Ovarian Cancer in Western Sweden: 10-Year Survival and Prognostic Factors (1 January, 2009)

  Margaretha Åkeson, Anne-Marie Jakobsen, Britt-Marie Zetterqvist, Erik Holmberg, Mats Brännström, György Horvath
• Clinical Trial Participation Is Associated With Improved Outcome in Women With Ovarian Cancer (1 January, 2009)

  William R. Robinson, Joyce Ritter, April S. Rogers, Sean Tedjarati, Christy Lieberenz
• The Functional Polymorphisms on Promoter Region of Matrix Metalloproteinase-12, -13 Genes May Alter the Risk of Epithelial Ovarian Carcinoma in Chinese (1 January, 2009)

  Yan Li, Jing-Hui Jia, Shan Kang, Xiao-Juan Zhang, Jian Zhao, Na Wang, Rong-Miao Zhou, Dong-Lan Sun, Ya-Nan Duan, Dong-Jie Wang